Investigational Site Number 1240002

Burlington L7N 3V2

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed